Next Article in Journal
Reliability Design of Mechanical Systems Such as Compressor Subjected to Repetitive Stresses
Previous Article in Journal
Photoactive Carbogenic Nanotracers With Remarkable Antimicrobial Properties for pH-Sensing Applications
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer †

by
Madalina Andreea Badea
1,*,
Mihaela Balas
1,
Florentina Gina Cojocaru
2,
Daniela Ionita
3 and
Anca Dinischiotu
1
1
Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, R-050095 Bucharest, Romania
2
Department of Anatomy, Physiology and Biophysics, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, R-050095 Bucharest, Romania
3
Department of General Chemistry, Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, 313 Splaiul Independentei, 060042 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Presented at the 2nd International Online-Conference on Nanomaterials, 15–30 November 2020; Available online: https://iocn2020.sciforum.net/.
Mater. Proc. 2021, 4(1), 32; https://doi.org/10.3390/IOCN2020-07989
Published: 12 November 2020
(This article belongs to the Proceedings of The 2nd International Online-Conference on Nanomaterials)

Abstract

:
Triple negative breast cancer has a phenotype characterized by the absence of progesterone and estrogen receptors and the lack of HER2 overexpression. In order to find new strategies for treatment, single-walled carbon nanotubes (SWCNT) in combination with chemotherapeutics were studied and tested as new therapeutic tools. The objective of this study was to evaluate the efficiency of SWCNT in the transport of cisplatin (CDDP) for improving its cytotoxic effects on MDA-MB-231 cells. The nanoconjugates SWCNT-COOH-CDDP were obtained by the functionalization of SWCNT with carboxyl groups (SWCNT-COOH) and conjugation with CDDP. MDA-MB-231 cells were exposed to different doses of SWCNT-COOH, SWCNT-COOH-CDDP (0.01–2 µg/mL), and CDDP (0.00632–1.26 µg/mL) for 24 and 48 h. Cellular viability was monitored through an MTT test. The level of reactive oxygen species (ROS) and reduced glutathione (GSH) were evaluated using fluorescence and spectrophotometric methods, respectively. The expressions of Nrf2, caspase-3, caspase-8, and Bid proteins were assessed by immunoblotting in the presence of 0.5 and 1 µg/mL nanoconjugates. Additionally, the effects of SWCNT-COOH-CDDP on cell migration were monitored using a wound healing assay. The cellular viability decreased and ROS level increased in a time and dose-dependent manner in the presence of nanoconjugates relative to the control. Moreover, the level of GSH rose after 24 and 48 h of exposure to 0.5 µg/mL SWCNT-COOH-CDDP, while a decrease to 78.31% was recorded after 48 h in the presence of 1 µg/mL nanoconjugates. The expression of Nrf2 decreased to 33% after 24 h of treatment with 1 µg/mL SWCNT-COOH-CDDP and increased to 80% compared to the control (100%) after 48 h. Upregulation of caspase-3 and caspase-8 and downregulation of Bid post-exposure to 1 µg/mL SWCNT-COOH-CDDP was noticed. The inhibition of cell migration was observed after 24 and 48 h of exposure to 1 µg/mL SWCNT-COOH-CDDP. In conclusion, these nanoconjugates induced apoptosis in MDA-MB-231 cells, probably by both intrinsic and extrinsic pathways, by triggering the oxidative stress mechanisms, and inhibited their migration potential.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/IOCN2020-07989.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Badea, M.A.; Balas, M.; Cojocaru, F.G.; Ionita, D.; Dinischiotu, A. Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer. Mater. Proc. 2021, 4, 32. https://doi.org/10.3390/IOCN2020-07989

AMA Style

Badea MA, Balas M, Cojocaru FG, Ionita D, Dinischiotu A. Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer. Materials Proceedings. 2021; 4(1):32. https://doi.org/10.3390/IOCN2020-07989

Chicago/Turabian Style

Badea, Madalina Andreea, Mihaela Balas, Florentina Gina Cojocaru, Daniela Ionita, and Anca Dinischiotu. 2021. "Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer" Materials Proceedings 4, no. 1: 32. https://doi.org/10.3390/IOCN2020-07989

Article Metrics

Back to TopTop